Chemoradiation with platinum-based chemo is standard for locally advanced cervical cancer, but adverse events drive ...

Aclaris' stock has dropped nearly 70% since September 2023, reflecting its history of failures and dissipations. Explore more ...

Observational studies are critical tools in clinical research and public health response, but challenges arise in ensuring ...

Acceptance follows resolution of third-party fill/finish manufacturing issuesFDA decision expected by July 10, 2025 TARRYTOWN, N.Y., Feb. 11, ...

Acceptance follows resolution of third-party fill/finish manufacturing issues FDA decision expected by July 10, 2025 TARRYTOWN, N.Y., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc.

Results from the PEACOCC trial warrant further investigation into treatment with pembrolizumab in patients with previously ...

“For decades, scientists have debated whether immune responses are random or follow set rules,” said Dr. Jingyi Xie, lead author of the study. “Our findings show that T cells follow a predictable ...

Northwestern Medicine investigators have developed a new avenue to reprogram compromised immune cells to act against tumors, ...

A revolutionary approach to immune therapy has emerged: engineered immune cells that protect healthy tissue without ...

Newborns with heart complications can rely on their newly developed immune systems to regenerate cardiac tissues, but adults aren't so lucky. After a heart attack, most adults struggle to regenerate ...

The SARS-CoV-2 pandemic interrupted much respiratory research. Respiratory clinical academics joined colleagues in providing clinical care, and global research efforts were directed to finding new ...

This eBook celebrates the achievements of inspiring women in life sciences, highlighting their journeys, challenges and ...